National Advertising Division Refers TWiiSH to the Federal Trade Commission for Review

New York, NY – May 30, 2024 – BBB National Programs' National Advertising Division has referred TWiish advertising claims and influencer practices for their “Peachy Clean” and “Zit Ain’t Cute” products to the Federal Trade Commission (FTC) after the company failed to provide a substantive response to the National Advertising Division’s (NAD) inquiry. 

Twiish is a skincare company targeting teenagers. The following are representative of the claims that served as the basis for this inquiry.

Express Claims

  • "The secret to clear, bump-free skin is TWiiSH" 
  • Peachy Clean and Zit Ain't Cute use "powerhouse ingredients such as salicylic acid and colloidal silver" that "effectively tackle pimples without stripping or drying out your skin"
  • "TWiiSH formulas meet an extra level of scientific validity making them friendly for adolescent skin types when analyzed for overarching pediatric dermatology criteria"

 

Implied Claim

  • TWiiSH has been tested on/is safe for adolescent skin. 

 

Influencer Practices

  • Influencers promote TWiiSH products without including sufficient or any disclosure of their material connection with the company.

 

Despite repeated outreach attempts, TWiiSH did not submit a substantive response to NAD’s inquiry or participate in the self-regulatory process. Per NAD/NARB Procedures, NAD has referred this matter to the FTC and appropriate platforms for review and possible enforcement action.

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB procedures, this release shall not be used for advertising or promotional purposes.

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

In National Advertising Division Challenge Admire Aesthetics Voluntarily Discontinues Claims for Compounded Tirzepatide

New York, NY – January 23, 2025 – In a BBB National Programs’ National Advertising Division challenge brought by Eli Lilly, Admire Aesthetics voluntarily discontinued certain advertising claims for its compounded tirzepatide product.

Read the Decision Summary
Decision

National Advertising Division Finds Certain Claims for Brainiac Applesauce and Gummy Vitamins Supported; Recommends Others be Discontinued or Modified

New York, NY – January 22, 2025 – The National Advertising Division determined that Ingenuity Brands provided a reasonable basis for certain claims for its Brainiac Brain Squeezers Applesauce products and BrainPack Daily Adult Gummy Vitamins, but recommended other claims be discontinued or...

Read the Decision Summary
Decision

National Advertising Division Recommends Procter & Gamble Modify or Discontinue Certain #1 Claims for Tide Free & Gentle

New York, NY – January 17, 2025 – The National Advertising Division recommended that P&G modify the claim “From Tide, the #1 brand used by dermatologists” when used in connection with imagery for Tide Free & Gentle and discontinue the related claim “From Tide, the #1 Trusted Detergent Brand for Sensitive...

Read the Decision Summary
Decision

National Advertising Division Recommends T-Mobile Discontinue “Families Can Save 20% Every Month Versus AT&T and Verizon” Claim

New York, NY – January 16, 2025 – In a Fast-Track SWIFT challenge brought by competitor AT&T, BBB National Programs’ National Advertising Division recommended T-Mobile discontinue its claim for 20% savings on monthly wireless services. 

Read the Decision Summary